GPC3 and breast cancer: Hh-signaling pathway: Also in breast cancer cells, Capurro MI et al. have reported that GPC3 is capable of triggering the endocytosis and subsequent degradation of the GPC3–Hh complex, thereby inhibiting Hh signaling [111], just as it does in fibroblast cells [42].